| abstract |
Compounds, compositions and methods for altering insulin secretion, particularly in the context of treatment of subjects having, or suspected of being at risk for having, diabetes mellitus. The compounds have the following struture (I): n n n including stereoisomers, prodrugs and pharmaceutically acceptable salts thereof, wherein W 1 , W 2 , X, R 1 , R 2 , R 3 , R 4 , m and n are defined herein. |